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Campylobacter jejuni causes gastroenteritis with a variety of symptoms in humans. In the absence of a 
suitable animal model, in vitro models have been used to study virulence traits such as invasion and toxin 
production. In this study one hundred and thirteen C. jejuni isolates from poultry and poultry-related (n=74) 
environments as well as isolates from human cases (n=39) of campylobacteriosis and bacteraemia, were 
tested for invasiveness using INT407 cells.  The method was sufficiently reproducible to observe a spectrum 
of invasiveness amongst strains.  As a result, strains were classified as low, high and hyper-invasive. The 
majority of strains (poultry and human) were low invaders (82 % and 88 % respectively).  High invasion was 
found for 5 % of human strains and 11 % of poultry-related isolates. However, only 1 % of poultry strains 
were classified as hyperinvasive compared to 13% of human isolates (P= 0.0182).  Of those isolates derived 
from the blood of bacteraemic patients 20% were hyperinvasive, though this correlation was not statistically 
significant.  An attempt was made to correlate invasiveness with the presence of 7 genes previously reported 
to be associated with virulence. Most of these genes did not correlate with invasiveness, but gene Cj0486 
was weakly overrepresented, and a negative correlation was observed for the gene ciaB. This trend was 
stronger when the two genes were analysed together, thus ciaB-Cj0486+ was overrepresented in high and 
hyperinvasive strains, with low invaders more commonly found to lack these genes (P=0.0064). 
 
INTRODUCTION 
Campylobacter jejuni is a common cause of bacterial enteritis in the industrialised world. In 2006 there were 
over 46,600 cases in England and Wales reported to the Health Protection Agency Centre for Infections 
(www.hpa.org.uk).  Due to under-reporting this is thought to reflect only about 12 % of the true incidence of 
campylobacteriosis (Tompkins et al., 1999).  Although the disease is generally self-limiting, the symptoms 
can be particularly debilitating, with severe abdominal pain and cramps followed by profuse diarrhoea. In 
developed countries disease symptoms indicate an inflammatory infection with blood-containing faeces, 
even when stools have a more watery appearance (Wassenaar & Blaser, 1999). Transient colonisation with 
few or no symptoms is more common in developing countries where individuals are constantly exposed to 
campylobacters.  Here individuals are thought to acquire a protective immune response from an early age 
(Newell, 2002).  Asymptomatic infection is rare in the developed world (Food Standards Agency, 2007), but 
has been reported for people who are frequently exposed to high doses in an occupational setting such as 
slaughterhouse workers or veterinarians (Cawthraw et al., 2000). This variation in clinical outcome most 
likely reflects both variations in the pathogenic potential of the infecting strain, and the immune status of the 
host, however the relative contributions of these two factors are presently unknown. 
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There have been extensive studies to investigate the disease mechanisms of C. jejuni.  The accepted 
mechanisms of pathogenesis are colonisation of the mucous layer of the intestine, adhesion to and invasion 
of the intestinal epithelial cells, and the production of one or more cytotoxins (Wassenaar & Blaser, 1999).  
The inflammatory nature of the disease, as well as strong evidence from in vivo studies (Newell & Pearson, 
1984; Ruiz-Palacios et al., 2007; Russell et al., 1993), suggest that invasion is an important virulence trait of 
this organism.  Many in vitro invasion assays, largely based upon gentamicin protection (Elsinghorst, 1994; 
Friis et al., 2005), have been developed and used to study the invasiveness of campylobacters using various 
cell lines including HEp2 (de Melo et al., 1989; Konkel & Joens, 1989), HeLa (Fauchere et al., 1986; Newell 
& Pearson, 1984), INT407 (Wassenaar et al., 1991) and Caco2 (Everest et al., 1992; Russell & Blake, 1994) 
cells.  Several invasion-related genes have been proposed as a consequence of such studies.  The flaA 
gene has been known for some time to be involved with invasion (Wassenaar et al, 1991) and motility of the 
organism is strongly linked to its invasive capacity.  More recently other genes have been implicated in 
invasion, notably cadF, a fibronectin binding protein that may provide a potential binding site for the 
bacterium (Konkel et al., 1997) with an additional involvement in cell signalling leading to GTPase activation 
(Krause-Gruszczynska et al., 2007); ciaB, which encodes one of eight proteins that are secreted upon 
contact with the host cell (Konkel et al., 1999); iam (invasion associated marker) identified following 
fingerprint analysis of invasive strains (Carvalho et al., 2001); and virB8, virB9 and virB11, which are present 
on the pVir plasmid, first identified in strain 81-176 (Bacon et al., 2000; Bacon et al., 2002). 
 
Variation in pathogenicity between strains is a common feature among many enteropathogens, including 
Salmonella enterica, Escherichia coli and Yersinia enterocolitica. Diversity between C. jejuni strains has 
been observed in various pathogenicity traits including adherence (Coote et al., 2007; Fauchère et al., 1986; 
Konkel & Joens, 1989; Zheng et al., 2006) and toxicity (Abu Oun et al., 2005; Bang et al., 2001; Bang et al., 
2003; Coote et al., 2007; Eyigor et al., 1999; Hänel et al., 2007;  Johnson & Lior, 1986; Lindblom et al., 
1990). Variation in invasion between strains of C. jejuni has also been demonstrated (Newell et al., 1985).  
Wide variation in adhesion and invasion were observed in isolates from retail meat (Zheng et al.,  2006) and 
unsuccessful attempts were made to correlate the presence or absence of known virulence-related genes to 
the phenotypes observed.  Similar results have been reported in other studies (Coote et al., 2007; Datta et 
al., 2003; Müller et al., 2006), suggesting that observable links between gene presence, genotype, isolation 
source or virulence potential, are rarely  observed, or extremely weak (Coote et al., 2007).   
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Risk attribution studies have identified poultry as a major source of human infection (Adak et al., 2005).  
Indeed, chickens are frequently colonized with Campylobacter and poultry meat is frequently contaminated 
(Jorgensen et al., 2002).  Nevertheless, differences in the population structures of human and poultry strains 
(Dingle et al., 2001; Koenraad et al., 1995; Krause-Gruszczynska et al., 2007; Manning et al., 2003a) 
suggest either that not all poultry Campylobacter strains possess the pathogenic potential to cause disease 
in man, or that not all poultry isolates survive meat processing and storage, thus never reaching the human 
consumer.  It seems likely that both explanations contribute to the observed differences in human and 
poultry C. jejuni populations. 
 
In this study we have investigated whether representative poultry isolates have the capacity to cause human 
disease using invasion as a surrogate marker of virulence. The invasion potential of 74 poultry and poultry-
related isolates was compared with that of 39 human clinical isolates, some of which were from blood and 
were therefore assumed to be invasive to the human host. In contrast the poultry isolates were, for the most 
part, epidemiologically-unrelated and had been obtained from asymptomatic birds and their environments. 
The results confirm variation in invasiveness among C. jejuni strains. A hyperinvasive group of strains has 
been identified; a greater proportion of which were found among the human isolates. The genetic 
relatedness of these strains was determined by multilocus sequence typing (MLST). In addition, the 
presence of putative invasion-related genes was investigated by PCR.   
 
METHODS 
Bacterial strains and growth conditions.  C. jejuni strains (n=66) were isolated from cloacal swabs of 
broilers, conventionally housed in farms within the South East of England, in 1996 and 1997.  Two additional 
poultry cloacal isolates and 6 broiler house environmental strains (taken from puddles around the broiler 
house) were isolated from a farm in the South West of England and were thus temporally and geographically 
related. 
 
Thirty-nine human C. jejuni clinical isolates were also investigated; 29 were isolated from the stools of 
patients with diarrhoea, who had presented to their general practitioner. The remaining ten strains were 
isolated from the blood of hospitalised patients with bacteraemia. 
 
Three laboratory-adapted Campylobacter strains, originally of clinical origin, of which the genome sequences 
are now known, were included as reference strains: C. jejuni strain NCTC 81116 originally isolated during a 
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water outbreak in the UK in 1981 (Palmer et al., 1983; Pearson et al., 2007); C. jejuni 81-176, bearing the 
pVir plasmid (Bacon et al., 2000; Hofreuter et al., 2006), which has previously been reported to be invasive 
(Oelschlaeger et al., 1993; Russell & Blake, 1994); and C. jejuni strain NCTC 11168, for which the first 
complete Campylobacter genome sequence was obtained (Parkhill et al., 2000). 
 
All strains used in this study were stored at -80 oC in 1 % (w/v) proteose peptone water containing 10 % (v/v) 
glycerol until required. Strains had been minimally passaged in vitro before storage and subsequent testing.  
When required bacteria were inoculated on blood agar containing selective Skirrow’s antibiotics (Oxoid, 
Basingstoke, UK) and Actidione (50 μgml-1) (BASA) and grown under microaerobic conditions at 42 oC. After 
24 h growth a loopful of bacteria was inoculated into pre-warmed brain heart infusion broth supplemented 
with 1 % (w/v) yeast extract (BHI/YE) overlaying BHI/YE agar. This was cultured for 20 h at 42 oC 
microaerobically for invasion assays.  These conditions were determined in preliminary studies as optimum 
growth conditions for the invasion assay. 
 
Invasion assay. The gentamicin protection assay used in this study was based on that of Elsinghorst 
(Elsinghorst, 1994).  INT407 cells, and later Caco2 cells, were obtained from the European Collection of 
Animal Cell Cultures (ECACC, CAMR, Porton Down, Salisbury).  Note that it is now generally recognised 
that the INT407 cell line was contaminated with HeLa cells in the 1970s and therefore has cellular markers 
consistent with this contamination.  Cells were maintained as a monolayer in Eagles Minimal Essential 
Medium (EMEM, Sigma) supplemented with 10 % (v/v) foetal bovine serum, 2 mM L-glutamine, 1 % (v/v) 
non-essential amino acids (NEAA) and 50 μg ml-1 gentamicin (complete media, all from Sigma) at 37 oC in a 
5% CO2 atmosphere. Confluent cultures were trypsinised, the cells counted and suspended in the above 
growth medium at a concentration of 2x105 cells ml-1. A 24 well tissue culture tray was seeded with 1ml per 
well and incubated at 37 oC for 48 h to establish confluent monolayers (approx. 5 x 105 cells per well for 
INT407 cells; or 3 x 105 cells per well for Caco2 cells). On the day of the assay the monolayers were washed 
twice with Hanks Balanced Salt Solution (HBSS, Sigma) to remove any residual antibiotics and incubated 
with 1 ml of a maintenance medium of EMEM, supplemented with 2 mM L-glutamine and 1 % (v/v) NEAA 
before use. Mid log phase campylobacters were harvested by centrifugation at 2100 g at room temperature 
and re-suspended in 0.1 M phosphate buffered saline pH 7.2 (PBS). Further dilutions into prewarmed EMEM 
were carried out to give a bacterial to cell ratio of 200:1. The viable count was determined retrospectively by 
culturing serial dilutions of the used suspension in PBS on BASA plates as before. 
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A volume of 0.1 ml of the bacterial suspension was inoculated into triplicate wells containing confluent 
monolayers of INT407 cells in 1 ml of maintenance medium. Tissue culture plates were centrifuged at 450 x 
g at room temperature for 15 min to bring the bacteria in contact with the cells. Centrifugation was carried out 
to eliminate variations in motility between strains, which could influence the outcome of the assay. Inoculated 
monolayers were incubated for 3 hours to allow the bacteria to invade the cells. After washing three times 
with HBSS, 2 ml of medium containing 250 µg ml-1 gentamicin was placed in each well and incubated for a 
further 2 hours to kill extracellular bacteria. Following incubation the monolayers were washed 3 times with 
HBSS and lysed with 1 % (v/v) Triton X-100 (Sigma) in PBS for 10 minutes at room temperature to release 
the intracellular bacteria. Serial dilutions of the suspensions were made in PBS and inoculated onto BASA 
plates to determine the number of organisms that survived the gentamicin treatment and hence had invaded 
the INT407 or Caco2 cells.  
 
The invasion efficiency of each isolate was expressed as a percentage of the number of bacteria added to 
the well at the start of the experiment with the standard error of the mean calculated from triplicate assays. 
Statistical analysis of the data was carried out using GraphPad Prism™ software version 2.01 (San Diego, 
CA, USA). Analysis of variance (ANOVA) with one factor was used to test for significant differences between 
the mean invasion efficiencies of the test isolates. Despite optimal standardisation of procedures, inter-
experimental variation remained considerable. Nevertheless, particular strains were consistently found low or 
highly invasive. One low invasive strain, C. jejuni NCTC 81116, was used as an internal control strain in all 
experiments and invasion potential of all other strains was related to this control strain using Dunnet’s post 
test analysis. Invasiveness was then plotted for all investigated strains, and cut-off values for hyper-invasive, 
highly invasive and low invasive strains were chosen as described in the Results section. The grouping of 
isolates into the invasion classes was reproducible irrespective of inter-experimental variation (data not 
shown).  
 
Translocation and association assays using alternative cell lines. To confirm the invasive capacity 
observed with INT407 cells, two more phenotypic characteristics were tested: the capacities to translocate 
across Caco-2 cell monolayers (Konkel et al., 1992) and to associate with HT29-Cl.16E mucus-secreting 
cells (Augeron et al., 1992). For translocation assays Caco-2 cells were grown on porous membrane inserts 
(3 µm pores) that were immersed in complete media.  The cells were allowed to differentiate into polarised 
monolayers for 14 days. Bacteria were placed in the upper compartment and allowed to associate with the 
apical surface of the Caco-2 cell surface. The ability of the bacteria to translocate was determined over time 
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by enumerating the number of bacteria that had passed through the cell monolayer into the lower 
compartment below the porous membrane insert.  
 
HT29-Cl.16E is a homogenous colonic epithelial goblet cell line (Augeron et al., 1992).  As gentamicin is 
unable to penetrate the mucus-secreted by this cell line, total association of the bacteria with these cells was 
measured. The assay was carried out as described above but after the initial three hour incubation the cells 
were lysed with Triton X-100 and the total number of bacteria that were in association and internalised was 
determined by viable count. 
 
Motility assay. To test whether variation in invasion corresponded with variation in motility the following 
motility studies were carried out.  Bacterial strains were grown as described on BASA plates, adjusted to a 
similar concentration spectrophotometrically, at a wavelength of 600nm, and 1 μl of the suspension was 
stabbed into semi-solid media (0.4% Muller Hinton agar). Both a test strain and a control strain were 
included on the same agar plate to avoid plate to plate variation. The plates were incubated as described for 
48 hours at 42 °C and the diameter of the halo of growth measured for each strain. Each strain was tested in 
triplicate. 
 
Scanning electron microscopy. Specimens were fixed for 16 hours in 3% (v/v) gluteraldehyde in 0.1M 
phosphate buffer, pH 7.4, washed in phosphate buffer and post fixed in 1% (w/v) osmium tetraoxide in the 
same buffer. Specimens were rinsed in six changes of phosphate buffer, dehydrated in ethanol and placed in 
acetone. Specimens were subjected to critical point drying with liquid carbon dioxide. Dried specimens were 
fixed to aluminium stubs with silver conductive paint, sputter coated with gold and examined using a Stereo-
scan S250 MarkIII scanning EM at 10-20 KV.  
 
PCR screening of isolates. PCR screening was conducted on a subset of strains (n= 61), selected on the 
basis of their invasion phenotype to determine the presence of invasion-related genes. PCR primers, as 
previously published, were used for detection of cadF iamA, virB11 and ciaB (Datta et al., 2003), Primers for 
virB8 and virB9 were derived from the C. jejuni strain 81-176 sequence (accession number AF226280) 
(virB8 FWD 5’-GCCATTACTTTTCTTGCCCC, virB8 REV: 5’-CGCTCCTTTCGTTTGTTGTG; virB9 FWD 5’- 
GTTCCTAACCCTAATGCAAAC, virB9 REV 5’- CTACACATACATAACTATCTCC). In addition to the 
published invasion-related genes, the presence of another gene, Cj0486, was determined since this gene 
was identified as having a potential role in the invasion of C. jejuni by transposon mutagenesis (Manning et 
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al., 2003b). Primers for gene Cj0486 were Cj0486 FWD 5' GATAGAGCATTAAATTGGGATG 3', and Cj0486 
REV 5' CCTATAAAGCCATACCAAGCC 3'.  Primers were used at a concentration of 10 pmol μL-1 and the 
pre-prepared PCR mastermix, HotStar Taq Polymerase, was used for the reactions (Qiagen, Crawley UK).  
PCR conditions were as follows: an initial denaturation step of 95 °C for 15 min, 25 cycles of: denaturation for 
45 sec at 95 °C; annealing for 45 sec at the temperature used by the authors in the above references, or 50 
°C, 50 °C and 58 °C for the virB8, virB9 and Cj0486 genes respectively; extension for 90 sec at 72 °C; 
followed by extension for 10 min.  
 
Multilocus sequence typing (MLST).  MLST was conducted on all the 61 isolates screened by PCR above 
using the primers and conditions previously described (Dingle et al., 2001; Manning et al., 2003a). 
 
RESULTS AND DISCUSSION 
Invasiveness of C. jejuni strains from poultry and poultry-related environments 
Invasiveness of the 74 poultry-associated strains was tested using INT407 cells and invasion was related to 
a low invasive control strain, C. jejuni NCTC 81116, to correct for inter-experimental variation. Invasiveness 
varied considerably between the investigated strains, as is shown in Figure 1. From the distribution profile 
obtained, three classes of relative invasiveness were defined. Strains that were at least 25 times as invasive 
than NCTC81116 were classified hyper-invasive and strains more than 10 times as invasive were classified 
as highly invasive. Below this level, strains were classified as low invaders. The cut-off level of 10 times the 
reference strain was chosen to divide low from high invaders since the distribution of invasiveness seems to 
drop at this level (as seen in Figure 1); below this cut-off invasion steadily decreases. The vast majority of 
strains (88 %) were thus classified as low invaders (between 0.0006 % to 0.3 % of the bacterial inoculum 
internalised).  Although these invasion efficiencies are low in comparison to those reported for invasive 
Salmonella (Finlay & Falkow, 1990; Huang et al., 1998), Shigella (Honma et al., 2000), Yersinia (Pepe & 
Miller, 1993) and E. coli (Boudeau et al., 1999) they are similar to those previously reported for C. jejuni 
(Biswas et al., 2000; Everest et al., 1992; Konkel & Joens, 1989; Tay et al., 1996). The number of strains per 
isolation source in each invasion class is summarized in Table 1. Of the poultry-related isolates, 11 % (8 of 
74 strains) were classed as highly invasive (between 0.3% and 1% of the inoculum internalised, whereas 
only EX114, a strain isolated from a puddle, possessed the hyper-invasive phenotype (1.2 % of the bacterial 
inoculum internalised). Interestingly, the other strains that were isolated at the same time from puddles 
surrounding the same poultry house were all found to be low invaders. 
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Invasive potential of clinical isolates. Campylobacter strains (n=39) isolated from patients with 
campylobacteriosis (enteritis and/or bacteraemia) also possessed a range of invasion phenotypes from low 
to hyperinvasive as previously defined (Table 1). However, a higher percentage of human isolates was found 
to be hyperinvasive (13 %) compared to poultry isolates (1 %). This difference was statistically significant (P= 
0.0182).  The proportion of low invaders varied very little between human and poultry isolates (82 % and 88 
% respectively), while of the clinical isolates only 5 % were highly invasive (compared to 11 % in poultry). 
The prevalence of hyperinvasive strains from patients with bacteraemia (20 %, Table 1) was higher than 
among the stool isolates (10 %) though this was not statistically significant (P= 0.3812).  Medical records of 
the cases from which the blood isolates originated showed that 3 of the 10 bacteraemic patients had prior 
debilitating conditions, such as neutropoenia or chronic renal failure, which may have rendered them more 
susceptible to bacteraemia. However, at least in some cases, bacteraemia may have been the result of 
infection with a more invasive strain.  Our data support a role for invasion in human disease as a greater 
proportion of human isolates were hyperinvasive compared with poultry isolates.  
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Several studies have compared the variation in invasiveness of clinical isolates with those of animal and 
environmental isolates (Biswas et al., 2000; Fernandez & Trabulsi, 1995; Konkel & Joens, 1989; Manninen 
et al., 1982; Newell et al., 1985; Tay et al., 1996).  Despite a low number of isolates tested in each of these 
studies, all studies have shown that the prevalence of invasive isolates is higher among clinical isolates than 
animal isolates and our data are in accordance to these previous reports. 
 
Confirmation of invasiveness using alternative cell lines.  It is well recognised that such INT407-based 
invasion assays poorly reflect the in vivo situation as a result of their de-differentiated status, There are some 
cell lines which more closely mimic the differentiated intestinal tract.  All six hyperinvasive strains identified 
within this study were subsequently tested for invasion of Caco2 cells grown as a monolayer (data not 
shown).  Five out of the six strains were invasive in Caco2 cells, one of which was over 4 times more 
invasive than the control and the other four had invasion efficiencies greater than 10 times that of the 
reference strain NCTC 81116, including one human clinical isolate, 01/51, maintaining a hyperinvasive 
phenotype in this cell line (26 times more invasive than NCTC 81116).  The sixth strain had a low invasive 
phenotype in Caco2 cells.  Three strains with a low invasive phenotype were also tested using Caco2 cells, 
all of which maintained this phenotype in the alternative cell line (data not shown).  The different invasion 
phenotypes observed using Caco2 cells may be due to inherent differences in the cell lines used (Friis et al., 
2005). 
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 Caco-2 cells under defined culture conditions can also be used to generate polarised and differentiated 
monolayers. Such organised cell systems are considered models of the intestinal epithelium. The ability of C. 
jejuni to translocate may also be a virulence property (Lee et al., 1986), particularly to enable access to the 
underlying gut epithelial tissues (Bras & Ketley, 1999; Everest et al., 1992; Konkel et al., 1992). The 
hyperinvasive puddle isolate (Ex114) and two low invasive strains (C. jejuni NCTC 81116 and a second 
puddle isolate Ex323 from the same farm as Ex114) were tested in the translocation model. All three strains 
possessed the ability to translocate, however large differences in their efficiencies were measured (Figure 2). 
The hyperinvasive puddle isolate was the most efficient at translocating through the monolayer.  
Approximately 14-fold more bacteria had passed through the monolayer after four hours compared to the 
two low invasive strains, both of which had low levels of translocation. These data support the INT407 cell 
invasion data. 
 
The hyperinvasive strain, Ex114, and the low invasive reference strain C. jejuni NCTC 81116 were also 
tested for their ability to associate (adhere and invade) with HT29-Cl.16E mucus-secreting cells. NCTC 
81116 demonstrated a low association with these cells while the hyperinvasive strain, Ex114, possessed a 
high association capacity (Figure 3). Increasing the number of bacteria added to the monolayer did not 
significantly increase association of NCTC 81116, which was approximately 40 fold lower than the 
hyperinvasive strain.  
 
The finding that selected hyperinvasive and low invasive strains retained their relative differences in 
invasiveness in these alternative tissue culture models provides supporting evidence that the INT407 cell 
assay is a suitable surrogate and objective measure of the invasion potential of C. jejuni. 
 
The hyperinvasive phenotype is not due to enhanced adhesion or motility. Scanning electron 
microscopy was used to visualise the number of bacteria of strains NCTC 81116 and Ex114 adhered to the 
mucous layer covering HT29-Cl.16E cells. No detectable differences in the abilities of these strains to adhere 
to the mucus were observed (data not shown). This suggests that the increased association demonstrated 
by the hyperinvasive strain to the HT29-Cl.16E cells is attributable to increased invasiveness, rather than to 
more efficient attachment.  
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The motility of the three C. jejuni strains representing the low and hyperinvasive phenotypes (Ex114, Ex323 
and NCTC 81116) was determined used semi-solid motility agar. All tested strains were fully motile, with a 
diameter of growth varying between 5.0 and 5.8 cm. As there was little difference in motility between hyper- 
and low invasive strains, it seems unlikely that motility influenced the invasion capacity.  
 
Prevalence of known virulence-related genes. Attempts were then made to correlate the invasion 
phenotype to particular genetic characteristics. The presence of six previously-reported invasion-associated 
genes was determined by PCR in 62 isolates (Table 2), selected to represent all sources and invasion 
phenotypes recognized. The three reference strains were also included. The genes studied included cadF, 
ciaB, iamA, virB8, virB9 and virB11. In addition, gene Cj0486 was included as it had been identified as 
potentially related to invasion by transposon mutagenesis (Manning et al., 2003b).   
 
The results of the PCRs are given in Table 2. The reference strain NCTC 11168 was found positive for all 
PCR reactions except iamA and the virB genes. Previous studies reported that NCTC 11168 does not 
contain the pVir plasmid (Bacon et al., 2000) and so absence of the virB genes was to be expected, however 
NCTC 11168 was thought to contain the iamA gene.  Comparison of the iamA gene sequence from NCTC 
11168 with that previously identified in an invasive strain (Carvalho, et al., 2001), from which strain the iamA 
PCR primers were derived, suggested that lack of conservation of the primer sequences could explain the 
absence of a PCR product from NCTC 11168.  The other two reference strains NCTC 81116 and 81176 also 
lacked the iamA gene as well as Cj0486 as was expected from their respective genome sequences 
(Hofreuter et al., 2007).  As expected strain 81176 possessed the three pVir-derived genes.  Although these 
three reference strains were originally isolated from clinical cases, their phenotypes may have changed over 
time as a consequence of  multiple laboratory passages (Gaynor et al., 2004). However, because the 
genome sequences are known for all three strains, this provides evidence of the validity of the PCR tests. 
 
 Only cadF was present in all isolates tested regardless of invasive phenotype or isolation source.  This 
confirmed previous studies of the prevalence of cadF (Datta et al., 2003; Dorrell et al., 2001; Müller et al., 
2006; Pearson et al., 2003; Zheng et al., 2006).  In contrast the other genes tested varied in presence from 
82 % (ciaB) to 2 % (virB9) of strains. The observed frequency is summarised for the three invasion potential 
classes and for the two main isolation sources (poultry and humans) in Table 3. None of the hyperinvasive 
strains possessed all of the genes investigated by PCR. Presence of the Cj0486 gene weakly correlated with 
invasive phenotype, in that 73 % of highly invasive strains were positive against 62% of the low-invasive 
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strains.  In contrast the ciaB gene showed a negative correlation to invasiveness as it was more common in 
low invasive strains compared to highly and hyperinvasive strains (Table 3). This finding contrasts with a 
prevalence approaching 100% for this gene, reported previously (Datta et al., 2003; Dorrell et al., 2001; 
Müller et al., 2006; Pearson et al., 2003; Zheng et al., 2006).  Considering these two genes together, a 
significant correlation was found (P=0.0064) for ciaB presence combined with Cj0486 absence: this pattern 
was found in 33 % of low invaders but only in 12 % of the combined highly or hyperinvasive strains.  
Conversely, ciaB absence combined with Cj0486 presence was found in 29 % of high or hyperinvasive 
strains, but only in 2 % of the low invaders (Table 3).  The observed correlations between presence or 
absence of Cj0486 and ciaB may or may not be causative; the genes may either encode proteins that 
enhance or reduce invasiveness, or they may be genetic markers for such a phenotype without encoding a 
product functional in invasion. That protein CiaB is produced upon contact with host cells (Rivera-Amill and 
Konkel, 1999) suggests a functional relationship with cell contact for this gene. However, the observed 
correlation described in this study suggests that this protein may limit invasion rather than promote it. 
Interestingly, mutagenesis of Cj0486 in the hyperinvasive C. jejuni strain 01/51 resulted in a mutant with a 
reduced invasion potential of just 10 % of that of the wild-type (Manning et al., 2003b), indicating a 
functional, positive relationship between the Cj0486 gene product and invasion.  The gene Cj0486 is 
annotated as a putative sugar transporter in NCTC11168 (Parkhill et al., 2000), with homology to fucP, 
encoding L-fucose permease, in C. jejuni strain RM1221 (Fouts et al., 2005).  It is likely that such a sugar 
transporter is located in the inner membrane and may be linked to chemotaxis as L-fucose is a reported 
chemoattractant of C. jejuni (Hugdahl et al., 1988).  It should be noted that the correlation with invasiveness 
cannot be explained by differences in chemotaxis or motility, as the invasion assay included centrifugation to 
overcome such differences, and a correlation between invasiveness and motility was not found, as 
discussed above. 
 
As the three genes virB11, virB8 and virB9 have been reported to encode type IV secretion proteins (Bacon 
et al., 2002) it seemed likely that these genes may play a role in cell contact or invasion.  Indeed mutational 
analysis of virB11 (Bacon et al., 2002) and virB9 (Bacon, et al., 2000) have indicated a significant role in 
invasion for these two genes.  Mutation of the virB11 gene resulted in an 11-fold reduction in invasion, and 
reduced virulence in the ferret model.  The virB11 gene was present in only 5 of the 62 (8 %) isolates in our 
study, which is consistent with other reports (Bacon et al., 2000; Datta et al., 2003). These 5 strains included 
one of the hyperinvasive strains and one of the highly invasive strains, however, the numbers involved are 
too small to draw any conclusions about association with invasiveness.  The three genes encoded by pVir 
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were only rarely found (Table 2), presumably reflecting the low prevalence of pVir, and usually (but not 
always) detected together.  Genes virB8 and virB9 were even less prevalent (3 % and 2 % respectively) than 
virB11, indicating diversity in the pVir genetic content.  
 
Surprisingly iamA was not found in human isolates but was present in 31 % of poultry isolates (Table 3). 
Similar observations have been reported (Rozynek et al., 2005) in Poland where 1.6% of isolates from Polish 
children, but 55 % of chicken isolates possessed this gene . In contrast a study testing only 11 strains from 
various sources (human enteritis, milk and bovine sources) detected the iamA gene in all strains (Müller et 
al., 2006).   
 
Clearly there are considerable discrepancies between studies attempting to correlate invasiveness with 
genomic content.  One possible explanation is the inherent limitations of gene detection using PCR. False-
negative results can be expected when a gene is polymorphic and the designed PCR primers do not detect 
the presence of particular orthologs. On the other hand, a gene may be present but mutated and non-
functional or not expressed, leading to a lack of correlation with phenotype. However, it seems much more  
likely that invasiveness is the result of the interplay of numerous genes, some of which may be redundant 
and others which may be interchangeable.  More comprehensive studies in the future using DNA 
microarrays may more accurately identify correlations between genotype and phenotype. 
  
Distribution of strains with known invasion potential amongst the MLST clonal complexes.  
The strains selected for this study were, to the best of our knowledge, not epidemiologically related. 
Nevertheless, we determined the phylogenetic relationship of all 62 strains selected above by MLST, to 
assess if the hyperinvasive strains were related. MLST analysis showed that the isolates were representative 
of 17 already-established sequence type (ST) complexes (http://pubmlst.org/campylobacter/) (Table 2). The 
ST21 complex was the most highly represented among the 62 isolates tested, with 22 strains belonging to 
this complex.  This is in line with previous reports in which this complex is highly represented within the C. 
jejuni population (Dingle et al., 2001; Manning et al., 2003a).  The remaining strains belonged to at least 16 
ST complexes; with each complex represented by up to 5 isolates within the 62 strains tested. There were 
also 4 isolates with sequence types that are so far unassigned to any ST complex (database last searched 
August, 2007). Four of the six hyperinvasive strains were part of the ST21 complex (3 were ST21 and one 
was ST916). Of the other two hyper-invasive strains one was ST914 (Ex114), which is part of the ST682 
complex and one was ST677 (0104), which is part of the ST677 complex.  Interestingly, the ST682 complex 
405 
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contains a number of isolates from wild bird sources (http://pubmlst.org/campylobacter/), suggesting that 
Ex114, which was isolated from a puddle on a farm, may well have originated from a wild bird, rather than a 
poultry source.   
 
Overall these results show that hyperinvasiveness is not restricted to strains belonging to a particular ST 
complex. All ST complexes represented in this study, excepting three (ST354, ST677, and ST682 complex) 
contained isolates with a low invasion potential, suggesting that this phenotypic group, too, is genetically 
diverse. Using Pearson’s Chi-square test, no association was found between ST complex and invasion 
potential. The majority of isolates belonging to the most common ST21 complex possessed cadF (100 %), 
Cj486 (100%) and ciaB (90 %) but only a minority possessed of cases iamA (13 %) or virB11 (13%). None of 
the ST21 isolates were ciaB+Cj486- and only 14 % were ciaB-Cj486+. These findings suggest that ST21 
complex isolates are no more likely to be invasive than those of other clonal complexes and in fact the 
combination ciaB-Cj486+, overrepresented in low invasive strains, is also overrepresented in ST21 isolates 
compared to the total number of isolates. 
 
In conclusion, using a relatively large number of isolates (n=113), we have shown that C. jejuni strains 
exhibit a range of invasion phenotypes, and that hyper-invasiveness is more frequently observed among 
human clinical isolates. Nevertheless, 82 % of clinical isolates have a low invasion phenotype and a similar 
proportion (88 %) was also found in poultry isolates.  Attempts to correlate the hyper- or high-invasiveness 
with the presence of putative invasion-associated genes indicated an association with the ciaB-Cj0486+ 
genotype but the molecular basis of this observation needs to be studied further.  Overall these results 
suggest that invasiveness in the host is a consequence of the interaction of multiple bacterial factors. 
However, it must also be considered that the outcome of infection with C. jejuni is highly dependant on the 
physiological and immunological status of the host.  
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Table 1: The invasiveness of C. jejuni isolates from poultry, the poultry environment (surrounding a broiler 
house) and human clinical isolates from both blood and faeces.  
633 
634 
635  
Source Number of strains displaying invasiveness† (% per 
isolation source) 
 Low High Hyper Total 
Poultry cloaca 60 (88%) 8 (12%) 0 68 
Poultry environment 5 (83%) 0 1 (17%) 6 
Poultry-related total 65 (88%) 8 (11%) 1 (1%) 74 
Human faecal 24 (83%) 2 (7%) 3 (10%) 29 
Human blood 8 (80%) 0 2 (20%) 10 
Human total 32 (82%) 2 (5%) 5 (13%) 39 
 636 
637 
638 
639 
640 
641 
642 
† Strains were grouped into the three invasion phenotypic groups according to their invasiveness compared 
to the control strain C. jejuni 81116 as rationalised in the text.  Isolates were classified as hyper-invasive, 
high and low invaders using the criteria explained in the text and as shown in Figure 1.  
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Table 2: MLST characterisation and prevalence of invasion-related genes amongst selected C. jejuni 
isolates (n=62) of human, poultry and poultry-related sources. 
643 
644 
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01 10 Human 21 21 Hyper + + + - - - -   
01 35 Human 21 21 Hyper + - + - - - -  3 
01 51 Human 21 21 Hyper + - + - - - -  3 
01 41 Human 21 916 Hyper + + + - - - -   
01 04 Human 677 677 Hyper + + - - - - - 3  
01 37 Human 21 21 High + - + - - - -  3 
01 38 Human 354 354 High + - + - - - -  3 
01 50 Human 21 19 Low + + + - - - -   
01 39 Human 21 53 Low + + + - - - -   
01 40 Human 21 53 Low + + + - - - -   
01 42 Human 21 104 Low + + + - - - -   
01 33 Human 21 943 Low + + + - - - -   
01 07 Human 22 22 Low + + - - - - - 3  
01 32 Human 22 22 Low + - - - - - -   
01 11 Human 45 137 Low + + - - - - - 3  
01 30 Human 45 45 Low + + - - - - - 3  
01 48 Human 48 48 Low + + + - - - -   
01 09 Human 52 52 Low + + + - - - -   
01 52 Human 52 775 Low + + + - - - -   
01 08 Human 61 61 Low + + - - - - - 3  
01 43 Human 257 257 Low + + + - - - -   
01 36 Human 354 324 Low + + + - - - -   
01 05 Human 508 508 Low + + - - - - - 3  
01 06 Human 677 677 Low + + - - + - - 3  
C322/12 Poultry U/A 436 High + - + - - - -  3 
C423/5 Poultry U/A 942 High + - - + - - -   
C423/7 Poultry U/A 942 High + - - + - - -   
C153/1 Poultry 21 21 High + + + - - - -   
C223/10 Poultry 21 21 High + + + - - - -   
C153/4 Poultry 52 63 High + + + - - - -   
C181/12 Poultry 52 910 High + + + - - - -   
C272/11 Poultry U/A 586 Low + + - - - - - 3  
C2/2 Poultry 21 21 Low + + + - - - -   
C201/8 Poultry 21 21 Low + + + - - - -   
C2/3 Poultry 21 21 Low + + + + - - -   
C13/4 Poultry 21 21 Low + + + - + - -   
C39/10 Poultry 21 44 Low + + + + - - -   
C1/1 Poultry 21 53 Low + + + - - - -   
C3/4 Poultry 21 104 Low + + + - + - -   
C27/7 Poultry 21 262 Low + + + - - - -   
C1/2 Poultry 21 489 Low + + + + - - -   
C216/11 Poultry 42 911 Low + - + + - - -  3 
C187/5 Poultry 45 45 Low + + - + - - - 3  
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C4/1 Poultry 48 475 Low + + + - - - -   
C4/6 Poultry 48 475 Low + + + - - - -   
C1/8 Poultry 49 907 Low + + + + - - -   
C70/6 Poultry 49 909 Low + + + - - - -   
C196/14 Poultry 49 915 Low + + - + - - - 3  
C181/2 Poultry 52 52 Low + + + + - - -   
C27/14 Poultry 257 257 Low + + + - - - -   
C35/4 Poultry 283 267 Low + + - - - - - 3  
C39/12 Poultry 283 267 Low + + - - - - - 3  
C110/4 Poultry 433 433 Low + + - - - - - 3  
C148/2 Poultry 433 433 Low + + - + - - - 3  
C69/7 Poultry 443 393 Low + + + - - - -   
C69/2 Poultry 443 393 Low + + + - - - -   
C12/11 Poultry 658 908 Low + + - - - - - 3  
Ex114 Puddle 682 914 Hyper + - - - + + -   
Ex403 Puddle 45 45 Low + - - - - - -   
Reference strains 
11168 Human 21 21 High + + + - - - -   
81176 Human 42 913 High + + - - + + + 3  
81116 Human 283 267 Low + + - - - - - 3  
645 
646 
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Table 3: Presence of predicted invasion-related genes in C. jejuni isolates with varying invasion potentials 
(top) and isolation source (bottom).  
647 
648 
649  
 Number of isolates (%) positive for each gene by PCR 
Invasion 
Potential 
cadF ciaB Cj0486 iamA virB11 virB8 virB9 ciaB+ 
Cj486- 
ciaB- 
Cj486+ 
Hyper 
(n=6) 
6 
(100%) 
3 
(50%) 
4 
(67%) 
0 
(0%) 
1 
(17%) 
1 
(17%) 
0 
(0%) 
1  
(17%) 
2 
(33%) 
High 
(n=11) 
11 
(100%) 
6 
(55%) 
8 
(73%) 
2 
(18%) 
1 
(9%) 
1  
(4%) 
1 
(4%) 
1 
(9%) 
3 
(27%) 
Low 
(n=45) 
45 
(100%) 
42 
(93%) 
28 
(62%) 
9 
(20%) 
3 
(7%) 
0 
(0%) 
0 
(0%) 
15 
(33%) 
1 
(2%) 
Total 
(n=62) 
62 
(100%) 
51 
(82%) 
40 
(65%) 
11 
(18%) 
5 
(8%) 
2 
(3%) 
1 
(2%) 
17 
(27%) 
6 
(10%) 
 Number of isolates (%) positive for each gene by PCR 
Isolation   
Source 
cadF ciaB Cj0486 iamA virB11 virB8 virB9 ciaB+ 
Cj486- 
ciaB- 
Cj486+ 
Poultry†  
(n=35) 
35 
(100%) 
29 
(83%) 
23 
(66%) 
11 
(31%) 
3 
(9%) 
1 
(3%) 
0 
(0%) 
8  
(24%) 
2  
(6%) 
Human†  
(n=27) 
27 
(100%) 
22 
(81%) 
17 
(63%) 
0 
(0%) 
2 
(7%) 
1  
(4%) 
1 
(4%) 
9 
(33%) 
4 
(17%) 
Total 
(n=62) 
62 
(100%) 
51 
(82%) 
40 
(65%) 
11 
(18%) 
5 
(8%) 
2 
(3%) 
1 
(2%) 
17 
(27%) 
6 
(10%) 
650 
651 
652 
653 
† Strains isolated from a puddle close to a poultry farm are included here as ‘poultry’ strains.  Reference 
strains that were originally isolated from human clinical cases are included here as ‘human’. 
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FIGURE LEGENDS  654 
655 
656 
657 
658 
659 
660 
661 
662 
663 
664 
665 
666 
667 
668 
669 
Figure 1.  Distribution of the 113 isolates tested for invasion into INT407 cells. Invasion is expressed in 
relation to the reference strain NCTC 81116 which is a relatively low invader. Three classes of invasiveness 
were defined: hyper-invasive strains are at least 25 times more invasive than the reference strain; high 
invasive strains are at least 10 times as invasive and low invaders are lower than 10 times as invasive as the 
reference strain. These findings were reproducible between individual experiments (not shown). 
 
Figure 2. Translocation of two C. jejuni strains through a monolayer of differentiated Caco-2 cells. The 
translocated fraction is shown for 6 time points. White bars: C. jejuni 81116; grey bars: C. jejuni strain Ex323; 
diagonal striped bars: C. jejuni  Ex114. 
 
Figure 3. Association of two C. jejuni strains to a monolayer of mucus-secreting cells. The fraction of 
associated bacteria, expressed as percentage of inoculum, is represented for triplicate experiments. 
Triangles: C. jejuni 81116; squares: C. jejuni strain Ex114.  
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